Picton Mahoney Asset Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-115	Closed	-$4K	–	957
2024 Q4	$4K	Buy	115 +15	+15%	+$522	﹤0.01%	544
2024 Q3	$4K	Buy	100 +73	+270%	+$2.92K	﹤0.01%	531
2024 Q2	$1K	Buy	+27	New	+$1K	﹤0.01%	562